|
Vol. 37 Nº 6 |
Lat. Am. J. Pharm. 37 (6): 1061-1272 (2018) |
REGULAR ARTICLES |
|
|
Determination of Sofosbuvir and Velpatasvir in Solid Pharmaceutical Dosage Form by HPLC-PDA and its Application to In Vitro Dissolution Studies *
TAHIR M.S., AHMED M., A.M.I., QADIR M.A., ADNAN A., RASHID A., SYED Q., HUSSAIN R., HIN L.K. & IKRAM R. (1067)
|
|
|
|
Impact of Injectable Solutions pH on Midazolam PK/PD Outcome After Bolus Administration *
IBARRA M., UMPIÉRREZ M., FAGIOLINO P. & VÁZQUEZ M. (1074)
|
|
|
|
Serum Metabolic Changes for Acute Paraquat Poisoning in Rats with Intervention of Curcumin *
CHEN L., PENG X., CHEN W., YANG X. & WANG S.CHEN L., PENG X., CHEN W. & YANG X. (1081)
|
|
|
|
Potential Anti-Oxidant and Anti-Inflammatory Effects of Losartan Against Thioacetamide-Induced Hepatic Damage in Rats *
MOSTAFA, R.E. (1089)
|
|
|
|
In Situ Synthesis, Encapsulation in Arabinoxylan and Release Kinetics of Microcrystalline Copper(II)-Aspirinate *
IRAM F., IQBAL M.S., KHAN A.H., AHMAD R. & SHER M. (1097)
|
|
|
|
Pharmaceutical Surveillance Study of Moxifloxacin Formulations: Therapeutic Perspective in Terms of Quality and Efficacy *
NAQVI G.R., NAQVI B.S., SHOAIB H.M., ALI H., ZAFAR F., PARVEEN S., SAEED R., NAZ S., KHAN Z., NAQVI T.S. & ALAM N. (1104)
|
|
|
|
Urine Metabolomics in Rats Treated by Alprazolam *
SUN F., JIANG Y., YU Z., ZHANG Z., HU L. & CAO G. (1115)
|
|
|
|
Heterocyclic Compounds Derivatives Inhibit Human Prostate Cancer Cells *
YU W., SONG L. & ZHU L. (1120)
|
|
|
|
A New Microporous Ca(II) Metal-Organic Framework for 5-Fluorouracil Loading and Inhibition of Human Osteogenic Sarcoma Cells *
ZHANG L., ZHANG F., CHEN X., & WU H. (1125)
|
|
|
|
Two New La(III) and Mg(II) Coordination Polymers: Inhibiting Growth of Human Ventricular Aneurysms *
XU W., PENG F., YUAN M., SUN Y., XU F. & GUO H. (1130)
|
|
|
|
Determination of Main Drug Content and Related Substances of New Compound Analgesic-Ketoprofen and Lansoprazole Sustained-Release Pellets *
WANG J., CHEN Y., ZHOU X., LIU S., LONG F., LUO L. & LUO Y. (1136)
|
|
|
|
Development of Sulfonamides of Contemporary Drugs as Anticancer Agents *
NADEEM R.A., QADIR M.A., AHMED M., SAJID I. & SHAHZADY T.G. (1144)
|
|
|
|
Nanonization and Characterization of Ketoprofen through Microchannel Fluidic Reactor *
KHAN J., BASHIR S., KHAN S., IHSAN A., KHAN A., SHAH S.W.A., KHAN B.A., KHAN N., GHAFAR R. & ISREB M. (1149)
|
|
|
|
Two novel Fe(II) and Zn(II) Metal Complexes: Inhibiting Growth of Human Lung Cancer Cells *
HUANG L., DONG L., ZHU J., & ZHENG Y. (1157)
|
|
|
|
A New 3D Ba(II)-Based Metal-Organic Framework as Anticancer Drug 5-Fu Carrier and Anti-Liver Cancer Study *
LIN X., HUANG Z., CHEN X., WU F., JIN R. & WU W. (1162)
|
|
|
|
Identification of Ketamine-addicted Animal Models Based on Radial Basis Function Network *
ZHANG X., ZENG M., WU B., SUN F., CHEN L., WANG X., & WANG X. (1168)
|
|
|
|
Design and Optimization of Pregabalin Conventional Release Formulations using Central Composite Design and Response Surface Methodology *
ASGHAR M.A., ZEHRAVI M., RAZA M.L., ASGHAR M.A., MUMTAZ N., NASIRI M.I. & REHMAN A.A. (1173)
|
|
|
|
The Effect of Esomeprazole on Postoperative Pain and Lung and Heart Complications in Rats *
ONK D., COSKUN R., ONK O.A., CIMEN F.K., KURT N., SULEYMAN B., MAMMADOV R., ALTUNER D., GUL V., MALKOC I., BILGIN A.O. & SULEYMAN H. (1182)
|
|
|
|
Two Novel Zn(II) and Ag(I) Metal Complexes: Inhibiting Growth of Human Lung Cancer Cells *
WEI J. & GE J. (1192)
|
|
|
|
Two Novel Complexes: Crystal Structures and Inhibiting Human Osteogenic Sarcoma Cells *
WANG M., PANG H., SUN J. & ZOU H. (1197)
|
|
|
|
How to Eliminate Curing Effect and Improve Storage Stability of Eudragit® NE 30D Coatings *
QADIR M.I., IRFAN M., ABBAS N., ZAHOOR A.F., SYED H.K., KHAN I., HUSSAIN A., ARSHAD M.S., & MOHSIN N.A. (1203)
|
|
|
|
Development and Validation of Novel Stability-Indicating LC Method to Determine Sitagliptin and Metformin in Presence of Degraded Products *
GURAV S.B. & BHATIA N.M. (1211)
|
|
|
|
Cytotoxicity Study of Capmul MCM and Vitamin E-TPGS *
RAVIKANTH P.V. & RAMANAMURHTY K.V. (1221)
|
|
|
|
Comprehensive In Vitro and In Silico Analyses of Differences in Inhibitory Propertiesof Taxifolin for Mammalian and Mushroom Tyrosinases *
CHOI Y., LIU L. & YI Y. (1226)
|
|
|
|
Validation of Spectroscopic Dissolution Method of Gatifloxacin: Statistical Comparison of In Vitro Therapeutic Equivalence and Quality Attributes *
ALI H., ZAFAR F., SHAREEF H., ISRAR F., PARVEEN S., NAWAB A., KHAN M.A., ALAM S., KHAN S., NAQVI G.R. & MAROOF K. (1231)
|
|
|
|
The Clinical Observation of Bifid Triple Viable Powder Combined with Hydrocortisone Butyrate Ointment in Treating Infantile Eczema *
ZHANG J., LIU H. & YANG Z. (1244)
|
|
|
|
Continuous Flow Processing: In situ Preparation of Imatinib Freebase *
WANG X., ZHAO C., CAO Y., YUAN Z., XU L. & ZHOU Y. (1251)
|
|
|
|
Novel 4-Hydroxycoumarin Derivatives: Anti-Cancer Effects on Human Oral Cancer Cells *
GAO L., LI S., GAO J., FENG H. & DING Z. (1257)
|
|
|
|
Morin Suppresses Cellular Invasion by Decreasing Nuclear Factor-κB-Mediated Matrix Metalloproteinase-9 Activity *
DILSHARA M.G., KARUNARATHNE W.A.H.M., MOLAGODA I.M.A., KANG C., CHOI Y.H. & KIM G. (1264)
|
|
|
_________________
* English
** Portugûes
|
|
|
ACTIONS ___ ___ _
Submit Article
Check Manuscript Status
Suscription
Free Sample Issue
STATISTICS ___ ___
JCR Impact Factor 2019:
0.240
Issues per year: 12
ISSN 0326 2383 (printed ed.)
ISSN 2362-3853 (on line ed.)
NEWSLETTER ___ ___
JOIN |
|